Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“

MISSION

Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.

AIM OF THE CONFERENCE

The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.

AREAS OF FOCUS

AI in cancer diagnosis/treatment

Computational methods for cancer research

Precision medicine with AI

Ethical, regulatory and governance issues of AI for health

Clinical translation of AI health interventions 

Innovative AI technologies/platforms

Interdisciplinary collaborations in cancer

SCIENTIFIC BOARD

Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg

Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel

Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg

Dr. Victor Greiff
University of Oslo, Norway

Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg

Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg

Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg

Prof. Christoph Merten
EPFL, Switzerland

Dr. Jan Moritz Middeke
University Hospital Dresden, Germany

Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg

Prof. Dr. Adriana Tomic
Boston University, USA

Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg

PRELIMINARY PROGRAM 2024

Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.


Session 2: Translating AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.

Session 3: Ethical, Regulatory and Governance Considerations
This session will examine ethical, regulatory and governance issues related to the development and deployment of AI and computational biology-powered cancer therapies. 

REGISTRATION

RECORDINGS OF THE PAST MEETING

If you like to receive the password, please contact sina.reis@comeed.ch

IMPRESSIONS OF THE PAST MEETING

To get the password please contact: sina.reis@comeed.ch

SPEAKERS 2022

Dr. Victor Greiff

University of Oslo, Norway

Dr. Ignacio Mastroleo

University of Buenos Aires, Argentina

Dr. Jan Moritz Middeke

University Hospital Dresden, Germany

Prof. Olaf Ronneberger

Google DeepMind, United Kingdom

Dr. Itay Tirosh

Weizmann Institute, Israel

Prof. Lena Maier-Hein

German Cancer Research Center, Germany

Prof. Christoph Merten

EPFL, Switzerland

Dr. Quaid Morris

Memorial Sloan Kettering Cancer Center, USA

Dr. Nikolaus Schultz

Memorial Sloan Kettering Cancer Center, USA

Dr. Adriana Tomic

University of Oxford, United Kingdom